Recent Publications

  1. Singhal, J., Nagaprashantha, L., Chikara, S., Awasthi, S., Horne, D., & Singhal, S.S. (2017). 2 '-Hydroxyflavanone: A novel strategy for targeting breast cancer. Oncotarget, 8(43), 75025-37. https://doi.org/10.18632/oncotarget.20499
  2. Desiderio, J., Chao, J., Melstrom, L., Warner, S., Tozzi, F., Fong, Y., Parisi, A., & Woo, Y. (2017). The 30-year experienced-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. European Journal of Cancer, 79, 1-14. https://doi.org/10.1016/j.ejca.2017.03.030
  3. Yuan, Y., Vora, N., Sun, C.L., Li, D.N., Soto-Perez-de-Celis, E., Mortimer, J., Luu, T.H., Somlo, G., Waisman, J., Smith, D., Chao, J., Katheria, V., Synold, T., Tran, V., Mi, S., Levi, A., Arsenyan, A., Choi, J., Zavala, L., Yost, S., & Hurria, A. (2017). Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer. Breast Cancer Research, 19, 101. https://doi.org/10.1186/s13058-017-0895-5
  4. Choueiri, T.K., Plimack, E., Arkenau, H.T., Jonasch, E., Heng, D.Y.C., Powles, T., Frigault, M.M., Clark, E.A., Handzel, A.A., Gardner, H., Morgan, S., Albiges, L., & Pal, S.K. (2017). Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. Journal of Clinical Oncology, 35(26), 2893-3001. https://doi.org/10.1200/jco.2017.72.2967
  5. Ma, X., Meng, Z., Jin, L., Xiao, Z., Wang, X., Tsark, W.M., Ding, L., Gu, Y., Zhang, J., Kim, B., He, M., Gan, X., Shively, J.E., Yu, H., Xu, R., & Huang, W. (2017). CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene, 36(28), 4060-71. https://doi.org/10.1038/onc.2017.16
  6. Aldoss, I., Song, J., Stiller, T., Nguyen, T., Palmer, J., O'Donnell, M., Stein, A.S., Marcucci, G., Forman, S., & Pullarkat, V. (2017). Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia. American Journal of Hematology, 92(9), 858-65. https://doi.org/10.1002/ajh.24783
  7. Herrmann, A., Lahtz, C., Nagao, T., Song, J.Y., Chan, W.C., Lee, H., Yue, C.Y., Look, T., Mulfarth, R., Li, W.Z., Jenkins, K., Williams, J., Budde, L.E., Forman, S., Kwak, L., Blankenstein, T., & Yu, H. (2017). CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity. Cancer Research, 77(18), 5118-28. https://doi.org/10.1158/0008-5472.can-16-0342
  8. Ahrens, B.J., Li, L., Ciminera, A.K., Chea, J., Poku, E., Bading, J.R., Weist, M.R., Miller, M.M., Colcher, D.M., & Shively, J.E. (2017). Diagnostic PET Imaging of Mammary Microcalcifications Using Cu-64-DOTA-Alendronate in a Rat Model of Breast Cancer. Journal of Nuclear Medicine, 58(9), 1373-9. https://doi.org/10.2967/jnumed.117.190850
  9. Liu, J.C., Wu, X.W., Zhang, H.Y., Pfeifer, G.P., & Lu, Q. (2017). Dynamics of RNA Polymerase II Pausing and Bivalent Histone H3 Methylation during Neuronal Differentiation in Brain Development. Cell Reports, 20(6), 1307-18. https://doi.org/10.1016/j.celrep.2017.07.046
  10. Sedrak, M.S., Myers, J.S., Small, D.S., Nachamkin, I., Ziemba, J.B., Murray, D., Kurtzman, G.W., Zhu, J.S., Wang, W.L., Mincarelli, D., Danoski, D., Wells, B.P., Berns, J.S., Brennan, P.J., Hanson, C.W., Dine, C.J., & Patel, M.S. (2017). Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests The PRICE Randomized Clinical Trial. JAMA Internal Medicine, 177(7), 939-45. https://doi.org/10.1001/jamainternmed.2017.1144
  11. Brose, M.S., Worden, F.P., Newbold, K.L., Guo, M., & Hurria, A. (2017). Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial. Journal of Clinical Oncology, 35(23), 2692-9. https://doi.org/10.1200/JCO.2016.71.6472
  12. Bloem, S.J., & Roep, B.O. (2017). The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes. Diabetologia, 60(7), 1185-9. https://doi.org/10.1007/s00125-017-4284-5
  13. Chen, Z., Li, S., Subramaniam, S., Shyy, J.Y.J., & Chien, S. Epigenetic Regulation: A New Frontier for Biomedical Engineers. In: Yarmush ML, editor. Annual Review of Biomedical Engineering, Vol 19. Palo Alto: Annual Reviews; 2017. p. 195-219.
  14. DeGregorio, G., Manga, S., Kiyang, E., Manjuh, F., Bradford, L., Cholli, P., Wamai, R., Ogembo, R., Sando, Z., Liu, Y.X., Sheldon, L.K., Nulah, K., Welty, T., Welty, E., & Ogembo, J.G. (2017). Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities. Oncologist, 22(7), 850-9. https://doi.org/10.1634/theoncolo-gist.2016-0383
  15. Zhang, K.Q., Wang, J.H., Tong, T.R., Wu, X.W., Nelson, R., Yuan, Y.C., Reno, T., Liu, Z., Yun, X.W., Kim, J.Y., Salgia, R., & Raz, D.J. (2017). Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma. International Journal of Cancer, 141(4), 766-77. https://doi.org/10.1002/ijc.30769
  16. Chlebowski, R.T., Aragaki, A.K., Anderson, G.L., Thomson, C.A., Manson, J.E., Simon, M.S., Howard, B.V., Rohan, T.E., Snetselar, L., Lane, D., Barrington, W., Vitolins, M.Z., Womack, C., Qi, L.H., Hou, L.F., Thomas, F., & Prentice, R.L. (2017). Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. Journal of Clinical Oncology, 35(25), 2919-26. https://doi.org/10.1200/jco.2016.72.0326
  17. Magilnick, N., Reyes, E.Y., Wang, W.L., Vonderfecht, S.L., Gohda, J., Inoue, J.I., & Boldin, M.P. (2017). miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression. Proceedings of the National Academy of Sciences of the United States of America, 114(34), E7140-E9. https://doi.org/10.1073/pnas.1706833114
  18. Lister, N., Shevchenko, G., Walshe, J.L., Groen, J., Johnsson, P., Vidarsdottir, L., Grander, D., Ataide, S.F., & Morris, K.V. (2017). The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene. Proceedings of the National Academy of Sciences of the United States of America, 114(37), 9942-7. https://doi.org/10.1073/pnas.1621490114
  19. Tran, T.Q., Lowman, X.H., & Kong, M. (2017). Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer. Clinical Cancer Research, 23(15), 4004-9. https://doi.org/10.1158/1078-0432.ccr-16-2506
  20. Chen, R., Zinzani, P.L., Fanale, M.A., Armand, P., Johnson, N.A., Brice, P., Radford, J., Ribrag, V., Molin, D., Vassilakopoulos, T.P., Tomita, A., von Tresckow, B., Shipp, M.A., Zhang, Y.H., Ricart, A.D., Balakumaran, A., Moskowitz, C.H., & Investigators, K.-. (2017). Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. Journal of Clinical Oncology, 35(19), 2125-32. https://doi.org/10.1200/jco.2016.72.1316
  21. Liu, C., Vyas, A., Kassab, M.A., Singh, A.K., & Yu, X. (2017). The role of poly ADP-ribosylation in the first wave of DNA damage response. Nucleic Acids Research, 45(14), 8129-41. https://doi.org/10.1093/nar/gkx565
  22. Chung, V., Mansfield, A.S., Braiteh, F., Richards, D., Durivage, H., Ungerleider, R.S., Johnson, F., & Kovach, J.S. (2017). Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial. Clinical Cancer Research, 23(13), 3277-84. https://doi.org/10.1158/1078-0432.ccr-16-2299
  23. Sun, G.H., & Riggs, A.D. (2017). A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi. Molecular Therapy-Nucleic Acids, 8, 345-55. https://doi.org/10.1016/j.omtn.2017.07.008
  24. Gu, Y., Zhang, J., Ma, X., Kim, B.W., Wang, H., Li, J., Pan, Y., Xu, Y., Ding, L., Yang, L., Guo, C., Wu, X., Wu, J., Wu, K., Gan, X., Li, G., Li, L., Forman, S.J., Chan, W.C., Xu, R., & Huang, W. (2017). Stabilization of the c-Myc Protein by CAMKIIgamma Promotes T Cell Lymphoma. Cancer Cell, 32(1), 115-28.e7. https://doi.org/10.1016/j.ccell.2017.06.001
  25. Lukas, R.V., Gondi, V., Kamson, D.O., Kumthekar, P., & Salgia, R. (2017). State-of-the-art considerations in small cell lung cancer brain metastases. Oncotarget, 8(41), 71223-33. https://doi.org/10.18632/oncotarget.19333
  26. Maia, M.C., Yang, E.S., Agarwal, N., & Pal, S.K. (2017). A step towards predicting checkpoint inhibitor response in kidney cancer. Lancet Oncology, 18(8), 982-3. https://doi.org/10.1016/S1470-2045(17)30533-8
  27. Li, M., Chen, Q., Ma, T., & Yu, X.C. (2017). Targeting reactive nitrogen species suppresses hereditary pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America, 114(27), 7106-11. https://doi.org/10.1073/pnas.1702156114
  28. Arentsen, L., Hansen, K.E., Yagi, M., Takahashi, Y., Shanley, R., McArthur, A., Bolan, P., Magome, T., Yee, D., Froelich, J., & Hui, S.K. (2017). Use of dual-energy computed tomography to measure skeletal-wide marrow composition and cancellous bone mineral density. Journal of Bone and Mineral Metabolism, 35(4), 428-36. https://doi.org/10.1007/s00774-016-0796-1
  29. Sun, V., Dumitra, S., Ruel, N., Lee, B., Melstrom, L., Melstrom, K., Woo, Y., Sentovich, S., Singh, G., & Fong, Y. (2017). Wireless Monitoring Program of Patient-Centered Outcomes and Recovery Before and After Major Abdominal Cancer Surgery. JAMA Surg, 152(9), 852-9. https://doi.org/10.1001/jamasurg.2017.1519